Yale Cancer Center Research Shows Former Diabetes Drug May Aid in Breast Cancer Treatment

This post was originally published on this site

Original post: December 10, 2021 9:20 am Newswise - Drug and Drug Abuse Yale Cancer Center Research Shows Former Diabetes Drug May Aid in Breast Cancer Treatment

Findings from a new study led by Yale Cancer Center show the small molecule inhibitor drug, PF05175157, originally developed to treat diabetes by Pfizer, may help in the treatment of breast cancer. The findings were reported today at the 2021 San Antonio Breast Cancer Symposium in San Antonio, Texas.